6.52 USD
▲+0.11+0.15%
盘后 6.52 +0.15%
2026-08-03
市值
$423.57M
市盈率
—
EPS
-1.04
股息率
—
52 周区间
5.04 – 9.32
成交量
250.47K
Beta
1.50
目标价
16.28
52W 低 5.0452W 高 9.32
价格走势
公司简介
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the ...